Recently, QIAGEN set out to investigate the performance of its market-leading miRNA testing platform. A key study released in 2014, the microRNA Quality Control Assessment (miRQC), examined the performance of a number of miRNA quantification systems, including the QIAGEN miScript System. In that study, QIAGEN performed quite well, showing high levels of reproducibility, accuracy and… Read article →
Day 2 of ASHG 2015 opened with a very interesting session on ASHG/ESHG Building Bridges, which focused on perceptions of clinical sequencing in the US and the EU. The 4-member panel included researchers from Columbia University, the US Food and Drug Administration (FDA), the Cyprus Institute of Neurology and Genetics and Our Lady’s Children’s Hospital,… Read article →
ASHG 2015 began yesterday with two great sessions. In the first, ASHG president Dr. Neil Risch reflected on the history of the organization and ASHG’s evolution over the years. In the second session, the Presidential Symposium on “Genetic Epidemiology at Scale: High Throughput Genomics Linked to Large Scale EHR systems,” Dr. Francis Collins talked about the precision… Read article →
Are you using or planning to use RNAseq in your research? If so, please help us understand your needs! Complete the global survey on RNAseq and find out how your fellow scientists are applying RNAseq technology in their research. Take the survey!
Numerous studies have concluded that it takes an average of 17 years for basic research discoveries to be translated into clinical practice (1). In the path from bench to bedside, however, not every discovery will fall within that middle range. Some take quite a bit longer, as in the case of circulating tumor cells (CTCs)… Read article →